Your browser doesn't support javascript.
loading
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Griesinger, Frank; Curigliano, Giuseppe; Subbiah, Vivek; Baik, Christina S; Tan, Daniel Sw; Lee, Dae H; Misch, Daniel; Garralda, Elena; Kim, Dong-Wan; van der Wekken, Anthonie J; Gainor, Justin F; Paz-Ares, Luis; Liu, Stephen V; Kalemkerian, Gregory P; Bowles, Daniel W; Mansfield, Aaron S; Lin, Jessica J; Smoljanovic, Vlatka; Rahman, Ahmadur; Zalutskaya, Alena; Louie-Gao, Melinda; Boral, Andy L; Mazières, Julien.
Affiliation
  • Griesinger F; Pius-Hospital, University of Oldenburg, Oldenburg, Germany.
  • Curigliano G; European Institute of Oncology, IRCCS, Milan, Italy.
  • Subbiah V; University of Milano, Milan, Italy.
  • Baik CS; Sarah Cannon Research Institute, Nashville, TN, USA.
  • Tan DS; University of Washington School of Medicine, Seattle, WA, USA.
  • Lee DH; National Cancer Centre Singapore, Singapore.
  • Misch D; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Garralda E; Helios Clinic Emil von Behring, Berlin, Germany.
  • Kim DW; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • van der Wekken AJ; Seoul National University College of Medicine & Seoul National University Hospital, Seoul, Republic of Korea.
  • Gainor JF; University of Groningen & University Medical Center Groningen, Groningen, Netherlands.
  • Paz-Ares L; Massachusetts General Hospital, Boston, MA, USA.
  • Liu SV; Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Kalemkerian GP; Georgetown University, Washington, DC, USA.
  • Bowles DW; University of Michigan, Ann Arbor, MI, USA.
  • Mansfield AS; University of Colorado School of Medicine, Aurora, CO, USA.
  • Lin JJ; Mayo Clinic, Rochester, NY, USA.
  • Smoljanovic V; Massachusetts General Hospital, Boston, MA, USA.
  • Rahman A; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Zalutskaya A; F. Hoffmann-La Roche, Ltd, Basel, Switzerland.
  • Louie-Gao M; Blueprint Medicines Corporation, Cambridge, MA, USA.
  • Boral AL; Blueprint Medicines Corporation, Cambridge, MA, USA.
  • Mazières J; Blueprint Medicines Corporation, Cambridge, MA, USA.
Future Oncol ; 20(6): 297-306, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37916501
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Future Oncol Year: 2024 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidines / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Limits: Humans Language: En Journal: Future Oncol Year: 2024 Type: Article Affiliation country: Germany